Published in Nucleic Acids Res on April 15, 2002
siRNAs can function as miRNAs. Genes Dev (2003) 16.08
A biochemical framework for RNA silencing in plants. Genes Dev (2003) 9.95
MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci U S A (2003) 8.73
Structural basis for overhang-specific small interfering RNA recognition by the PAZ domain. Nature (2004) 7.63
Sequence requirements for micro RNA processing and function in human cells. RNA (2003) 7.46
Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol (2007) 6.43
MicroRNA control of PHABULOSA in leaf development: importance of pairing to the microRNA 5' region. EMBO J (2004) 6.27
Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res (2004) 5.46
Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov (2010) 4.25
Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res (2003) 3.85
Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res (2003) 3.39
Designing siRNA that distinguish between genes that differ by a single nucleotide. PLoS Genet (2006) 3.23
HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res (2005) 2.93
Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cells. Proc Natl Acad Sci U S A (2002) 2.85
Functional polarity is introduced by Dicer processing of short substrate RNAs. Nucleic Acids Res (2005) 2.83
The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides. Nucleic Acids Res (2003) 2.64
The contributions of dsRNA structure to Dicer specificity and efficiency. RNA (2005) 2.48
An accurate and interpretable model for siRNA efficacy prediction. BMC Bioinformatics (2006) 2.46
A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites. Nucleic Acids Res (2005) 2.27
RNA interference: biology, mechanism, and applications. Microbiol Mol Biol Rev (2003) 2.19
Argonaute divides its RNA guide into domains with distinct functions and RNA-binding properties. Cell (2012) 2.07
Roles of AUF1 isoforms, HuR and BRF1 in ARE-dependent mRNA turnover studied by RNA interference. Nucleic Acids Res (2004) 1.99
DEQOR: a web-based tool for the design and quality control of siRNAs. Nucleic Acids Res (2004) 1.97
Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver. J Clin Invest (2010) 1.91
Structural basis for microRNA targeting. Science (2014) 1.77
Effect of target secondary structure on RNAi efficiency. RNA (2007) 1.76
Identification of a novel human nuclear-encoded mitochondrial poly(A) polymerase. Nucleic Acids Res (2004) 1.73
Efficient siRNA selection using hybridization thermodynamics. Nucleic Acids Res (2007) 1.68
Similar behaviour of single-strand and double-strand siRNAs suggests they act through a common RNAi pathway. Nucleic Acids Res (2003) 1.66
High-throughput selection of effective RNAi probes for gene silencing. Genome Res (2003) 1.65
Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs. J Virol (2004) 1.61
Argonaute protein identity and pairing geometry determine cooperativity in mammalian RNA silencing. RNA (2011) 1.59
Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. Blood (2005) 1.54
Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration. J Cell Biol (2005) 1.49
Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting. RNA (2007) 1.46
Computational estimation and experimental verification of off-target silencing during posttranscriptional gene silencing in plants. Plant Physiol (2006) 1.43
Functional siRNA expression from transfected PCR products. RNA (2002) 1.42
Control of transient, resurgent, and persistent current by open-channel block by Na channel beta4 in cultured cerebellar granule neurons. Proc Natl Acad Sci U S A (2010) 1.40
Intronic microRNA (miRNA). J Biomed Biotechnol (2006) 1.40
Functional dissection of siRNA sequence by systematic DNA substitution: modified siRNA with a DNA seed arm is a powerful tool for mammalian gene silencing with significantly reduced off-target effect. Nucleic Acids Res (2008) 1.37
Technical variables in high-throughput miRNA expression profiling: much work remains to be done. Biochim Biophys Acta (2008) 1.36
Nucleotide sequence homology requirements of HIV-1-specific short hairpin RNA. Nucleic Acids Res (2003) 1.35
Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand. J Virol (2005) 1.30
Gene silencing in Caenorhabditis elegans by transitive RNA interference. RNA (2003) 1.27
A systematic analysis of the effect of target RNA structure on RNA interference. Nucleic Acids Res (2007) 1.27
Effects on RNAi of the tight structure, sequence and position of the targeted region. Nucleic Acids Res (2004) 1.26
An enhanced U6 promoter for synthesis of short hairpin RNA. Nucleic Acids Res (2003) 1.24
Global analysis of the mammalian RNA degradome reveals widespread miRNA-dependent and miRNA-independent endonucleolytic cleavage. Nucleic Acids Res (2011) 1.24
Dissecting systemic RNA interference in the red flour beetle Tribolium castaneum: parameters affecting the efficiency of RNAi. PLoS One (2012) 1.23
Thermodynamic instability of siRNA duplex is a prerequisite for dependable prediction of siRNA activities. Nucleic Acids Res (2007) 1.22
Delivery systems for the direct application of siRNAs to induce RNA interference (RNAi) in vivo. J Biomed Biotechnol (2006) 1.21
Effect of base modifications on structure, thermodynamic stability, and gene silencing activity of short interfering RNA. RNA (2007) 1.16
Determinants of specific RNA interference-mediated silencing of human beta-globin alleles differing by a single nucleotide polymorphism. Proc Natl Acad Sci U S A (2006) 1.15
Prevention of HIV-1 infection in human peripheral blood mononuclear cells by specific RNA interference. Nucleic Acids Res (2002) 1.15
Integrated siRNA design based on surveying of features associated with high RNAi effectiveness. BMC Bioinformatics (2006) 1.15
Retracted siRNAs generated by recombinant human Dicer induce specific and significant but target site-independent gene silencing in human cells. Nucleic Acids Res (2003) 1.14
Targeted disruption of genes in the Bombyx mori sex pheromone biosynthetic pathway. Proc Natl Acad Sci U S A (2006) 1.12
Crystal structure, stability and in vitro RNAi activity of oligoribonucleotides containing the ribo-difluorotoluyl nucleotide: insights into substrate requirements by the human RISC Ago2 enzyme. Nucleic Acids Res (2007) 1.11
Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape. J Virol (2005) 1.10
Relative gene-silencing efficiencies of small interfering RNAs targeting sense and antisense transcripts from the same genetic locus. Nucleic Acids Res (2004) 1.10
RNAi: a potential new class of therapeutic for human genetic disease. Hum Genet (2011) 1.10
Cell surface proteomics identifies molecules functionally linked to tumor cell intravasation. J Biol Chem (2008) 1.09
Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cells. BMC Cancer (2010) 1.08
A simple and cost-effective method for producing small interfering RNAs with high efficacy. Nucleic Acids Res (2003) 1.06
RNAi for treating hepatitis B viral infection. Pharm Res (2007) 1.05
Profilin is required for viral morphogenesis, syncytium formation, and cell-specific stress fiber induction by respiratory syncytial virus. BMC Microbiol (2003) 1.03
RNA interference of LRRK2-microarray expression analysis of a Parkinson's disease key player. Neurogenetics (2007) 1.03
Influence of RT-qPCR primer position on EGFR interference efficacy in lung cancer cells. Biol Proced Online (2010) 1.03
Tolerated wobble mutations in siRNAs decrease specificity, but can enhance activity in vivo. Nucleic Acids Res (2005) 1.02
sIR: siRNA Information Resource, a web-based tool for siRNA sequence design and analysis and an open access siRNA database. BMC Bioinformatics (2007) 1.02
The effects of stem length and core placement on shRNA activity. BMC Mol Biol (2011) 1.00
Multiplexing siRNAs to compress RNAi-based screen size in human cells. Nucleic Acids Res (2007) 0.98
Comprehensive search for HNF-1beta-regulated genes in mouse hepatoma cells perturbed by transcription regulatory factor-targeted RNAi. Nucleic Acids Res (2004) 0.98
The use of RNAi-based screens to identify host proteins involved in viral replication. Future Microbiol (2010) 0.97
RNA interference-mediated virus clearance from cells both acutely and chronically infected with the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol (2005) 0.97
Independent combinatorial effect of antisense oligonucleotides and RNAi-mediated specific inhibition of the recombinant rat P2X3 receptor. Nucleic Acids Res (2003) 0.97
Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer. Br J Cancer (2007) 0.96
Co-expression of anti-NFkappaB RNA aptamers and siRNAs leads to maximal suppression of NFkappaB activity in mammalian cells. Nucleic Acids Res (2006) 0.95
Transgene-induced silencing of the zoosporogenesis-specific NIFC gene cluster of Phytophthora infestans involves chromatin alterations. Eukaryot Cell (2007) 0.95
Silencing the HaHR3 gene by transgenic plant-mediated RNAi to disrupt Helicoverpa armigera development. Int J Biol Sci (2013) 0.95
siRecords: a database of mammalian RNAi experiments and efficacies. Nucleic Acids Res (2008) 0.95
Small interference RNA targeting tissue factor inhibits human lung adenocarcinoma growth in vitro and in vivo. J Exp Clin Cancer Res (2011) 0.94
Efficient RNA interference depends on global context of the target sequence: quantitative analysis of silencing efficiency using Eulerian graph representation of siRNA. Nucleic Acids Res (2004) 0.94
Multi-task learning for cross-platform siRNA efficacy prediction: an in-silico study. BMC Bioinformatics (2010) 0.94
Efficient prediction of siRNAs with siRNArules 1.0: an open-source JAVA approach to siRNA algorithms. RNA (2006) 0.93
Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screens. FASEB J (2012) 0.93
Silencing of hepatitis A virus infection by small interfering RNAs. J Virol (2006) 0.93
A novel approach for evaluating the efficiency of siRNAs on protein levels in cultured cells. Nucleic Acids Res (2004) 0.93
Potent subunit-specific effects on cell growth and drug sensitivity from optimised siRNA-mediated silencing of ribonucleotide reductase. J RNAi Gene Silencing (2009) 0.92
Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology. Mol Pharm (2009) 0.92
siRNA efficiency: structure or sequence-that is the question. J Biomed Biotechnol (2006) 0.92
A structural interpretation of the effect of GC-content on efficiency of RNA interference. BMC Bioinformatics (2009) 0.91
Detection of siRNA induced mRNA silencing by RT-qPCR: considerations for experimental design. BMC Res Notes (2010) 0.91
Approximate Bayesian feature selection on a large meta-dataset offers novel insights on factors that effect siRNA potency. Bioinformatics (2009) 0.91
Surveillance of siRNA integrity by FRET imaging. Nucleic Acids Res (2007) 0.90
Complete, gene-specific siRNA libraries: production and expression in mammalian cells. RNA (2005) 0.90
Modeling recursive RNA interference. PLoS Comput Biol (2008) 0.89
Gene silencing by RNAi in mouse Sertoli cells. Reprod Biol Endocrinol (2008) 0.88
Divergent MicroRNA targetomes of closely related circulating strains of a polyomavirus. J Virol (2013) 0.87
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature (1998) 72.56
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell (1993) 64.62
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (2001) 57.23
Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biol (1999) 41.48
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature (2000) 39.31
Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature (2001) 38.75
A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science (2001) 31.33
RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev (2001) 26.16
How cells respond to interferons. Annu Rev Biochem (1998) 24.27
An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature (2000) 23.17
A species of small antisense RNA in posttranscriptional gene silencing in plants. Science (1999) 19.34
Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature (2000) 15.98
Argonaute2, a link between genetic and biochemical analyses of RNAi. Science (2001) 15.32
The rde-1 gene, RNA interference, and transposon silencing in C. elegans. Cell (1999) 13.48
Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J (2001) 12.88
ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell (2001) 10.20
Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III. Nature (2000) 9.82
On the role of RNA amplification in dsRNA-triggered gene silencing. Cell (2001) 9.78
Use of double-stranded RNA interference in Drosophila cell lines to dissect signal transduction pathways. Proc Natl Acad Sci U S A (2000) 9.02
Mut-7 of C. elegans, required for transposon silencing and RNA interference, is a homolog of Werner syndrome helicase and RNaseD. Cell (1999) 9.01
Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev (1999) 8.21
Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway. Cell (1998) 7.74
RNA interference--2001. Genes Dev (2001) 7.68
Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci U S A (2001) 7.12
Gene silencing as an adaptive defence against viruses. Nature (2001) 5.73
Functional anatomy of a dsRNA trigger: differential requirement for the two trigger strands in RNA interference. Mol Cell (2000) 5.18
RNA silencing in plants--defense and counterdefense. Science (2001) 5.01
RNA interference: listening to the sound of silence. Nat Struct Biol (2001) 4.05
Genetic requirements for inheritance of RNAi in C. elegans. Science (2000) 4.04
Transgene and transposon silencing in Chlamydomonas reinhardtii by a DEAH-box RNA helicase. Science (2000) 3.84
RNAi as random degradative PCR: siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs. Cell (2001) 3.80
Mitochondrial endonuclease G is important for apoptosis in C. elegans. Nature (2001) 2.76
A novel mRNA-decapping activity in HeLa cytoplasmic extracts is regulated by AU-rich elements. EMBO J (2001) 2.63
RNA interference in Trypanosoma brucei: cloning of small interfering RNAs provides evidence for retroposon-derived 24-26-nucleotide RNAs. RNA (2001) 2.61
dsRNA-mediated gene silencing in cultured Drosophila cells: a tissue culture model for the analysis of RNA interference. Gene (2000) 2.52
The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J Biol Chem (2001) 2.47
RNA interference and small interfering RNAs. Chembiochem (2001) 2.40
A short primer on RNAi: RNA-directed RNA polymerase acts as a key catalyst. Cell (2001) 2.15
The major mRNA-associated protein YB-1 is a potent 5' cap-dependent mRNA stabilizer. EMBO J (2001) 2.15
Functional characterization of SR and SR-related genes in Caenorhabditis elegans. EMBO J (2000) 2.05
Short 5'-phosphorylated double-stranded RNAs induce RNA interference in Drosophila. Curr Biol (2001) 1.91
Use of cDNA subtraction and RNA interference screens in combination reveals genes required for germ-line development in Caenorhabditis elegans. Proc Natl Acad Sci U S A (2001) 1.88
Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res (1996) 1.52
Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes. Nucleic Acids Res (2000) 1.44
Essential roles for four cytoplasmic intermediate filament proteins in Caenorhabditis elegans development. Proc Natl Acad Sci U S A (2001) 1.25
Opposite sorting of tissue factor in human umbilical vein endothelial cells and Madin-Darby canine kidney epithelial cells. Blood (1996) 0.94
Characterization of PSKH1, a novel human protein serine kinase with centrosomal, golgi, and nuclear localization. Genomics (2000) 0.88
Effects of binding of ligand (FVIIa) to induced tissue factor in human endothelial cells. Thromb Res (2000) 0.86
Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res (2003) 3.85
The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cells. RNA (2005) 3.14
An algorithm for selection of functional siRNA sequences. Biochem Biophys Res Commun (2004) 2.84
Functional polarity is introduced by Dicer processing of short substrate RNAs. Nucleic Acids Res (2005) 2.83
Similar behaviour of single-strand and double-strand siRNAs suggests they act through a common RNAi pathway. Nucleic Acids Res (2003) 1.66
A facile lentiviral vector system for expression of doxycycline-inducible shRNAs: knockdown of the pre-miRNA processing enzyme Drosha. Mol Ther (2007) 1.34
Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors. Oncogene (2002) 1.31
Chemical modification patterns compatible with high potency dicer-substrate small interfering RNAs. Oligonucleotides (2008) 1.17
A role for human Dicer in pre-RISC loading of siRNAs. Nucleic Acids Res (2010) 1.11
Knockdown of C-terminal Src kinase by siRNA-mediated RNA interference augments T cell receptor signaling in mature T cells. Eur J Immunol (2004) 1.04
Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells. Clin Cancer Res (2006) 1.00
Short-interfering RNA-mediated Lck knockdown results in augmented downstream T cell responses. J Immunol (2005) 0.92
The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor. Thromb Res (2006) 0.89
Downregulation of tissue factor by RNA interference in human melanoma LOX-L cells reduces pulmonary metastasis in nude mice. Int J Cancer (2004) 0.89
Active transcriptomic and proteomic reprogramming in the C. elegans nucleotide excision repair mutant xpa-1. Nucleic Acids Res (2013) 0.89
Factor VIIa induces tissue factor-dependent up-regulation of interleukin-8 in a human keratinocyte line. J Biol Chem (2002) 0.88
Human TNF-alpha in transgenic mice induces differential changes in redox status and glutathione-regulating enzymes. FASEB J (2002) 0.86
Down-regulated expression of PPARalpha target genes, reduced fatty acid oxidation and altered fatty acid composition in the liver of mice transgenic for hTNFalpha. Biochim Biophys Acta (2005) 0.85
PSKH1, a novel splice factor compartment-associated serine kinase. Nucleic Acids Res (2002) 0.84
Loss of Caenorhabditis elegans UNG-1 uracil-DNA glycosylase affects apoptosis in response to DNA damaging agents. DNA Repair (Amst) (2010) 0.82
Transport signals and transcription-dependent nuclear localization of the putative DEAD-box helicase MDDX28. J Biol Chem (2003) 0.82
The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells. Thromb Haemost (2004) 0.82
Involution of thymus and lymphoid depletion in mice expressing the hTNF transgene. APMIS (2004) 0.80
Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease. Thromb Res (2004) 0.80
Gene Expression Profiling during Murine Tooth Development. Front Genet (2012) 0.79
Regulated compartmentalization of the putative DEAD-box helicase MDDX28 within the mitochondria in COS-1 cells. Exp Cell Res (2004) 0.78
Mutants of the protein serine kinase PSKH1 disassemble the Golgi apparatus. Exp Cell Res (2003) 0.78
Two novel mutations in the human coagulation factor VII promoter. Thromb Haemost (2003) 0.77
The changing faces of tissue factor biology. A personal tribute to the understanding of the "extrinsic coagulation activation". Thromb Haemost (2007) 0.76
Regulated expression of a transgene introduced on an oriP/EBNA-1 PAC shuttle vector into human cells. BMC Biotechnol (2009) 0.75
Meeting Review: ESF workshop on 'Impact of nucleic acid chemistry on gene function analysis: antisense, aptamers, ribozymes and RNAi'. Comp Funct Genomics (2002) 0.75
A novel gene mutation in the 60s loop of human coagulation factor VII - inhibition of interdomain crosstalk. Thromb Haemost (2004) 0.75
Gene targeting of tissue factor, factor X, and factor VII in mice: their involvement in embryonic development. Biochemistry (Mosc) (2002) 0.75
Construction and expression of oligonucleotide-based antisense cassettes. Cold Spring Harb Protoc (2011) 0.75
Effects of dietary fat quantity and composition on fasting and postprandial levels of coagulation factor VII and serum choline-containing phospholipids. Br J Nutr (2003) 0.75